US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Healthcare Deals This Week: Merck, Novartis And More No Photo Available

Yeji Jesse Lee

It was deal after deal this past week, as Big Pharma continued to scoop up companies.

What To Know As Sen. Cassidy Proposes Changes To 340B No Photo Available

Mark Payne

Newly introduced Senate legislation could radically change the scope of the 340B drug discount program, including by altering how prov... (more story)

Remedies, Not Suits: How FTC Approaches Health Mergers No Photo Available

Yeji Jesse Lee

The Federal Trade Commission has not sued over any healthcare provider mergers since President Donald Trump's return to the White Hous... (more story)